Development

Latest News

breast cancer | Image credit: Romolo Tavani - stock.adobe.com
New Data Show Safety of Ado-Trastuzumab, Trastuzumab Biosimilars in HER2+ Cancers

June 11th 2024

Posters from the American Society of Clinical Oncology annual meeting showcased safety and efficacy data for a trastuzumab biosimilar and an ado-trastuzumab biosimilar in HER2-positive (HER2+) cancers.

Biosimilars Check-In banner
Biosimilars Check-In: Application Acceptances, European Approvals, New Partnerships

June 6th 2024

digestive tract | Image credit: Grispb - stock.adobe.com
DDW 2024 Posters Evaluate Safety, Efficacy, Impact of BMI on Zymfentra Use

May 21st 2024

50 | Image credit: ink drop - stock.adobe.com
BioRationality: FDA Pridefully Declares 50th Biosimilar Approval

May 20th 2024

vials AI generated | Image credit: pixardi - stock.adobe.com
Partnering for Biosimilar Security: India's Role in US Health Care Savings, Supply Chain Stability

May 9th 2024

Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CFB podcast banner
"SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars" with the CfB logo and an image of an eye
cfb podcast banner
CfB podcast banner
CfB podcast banner

More News

© 2024 MJH Life Sciences

All rights reserved.